HOME › DRUGS › LIFILEUCEL
ACTIVE SUBSTANCE / INN

LIFILEUCEL

Brand name(s): Amtagvi
EMA LISTED
APPLICATION WITHDRAWN
Melanoma
ACTIVE SUBSTANCE
Lifileucel
REGULATORS
EMA
SPONSORS / MAH
Iovance Biotherapeutics B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AmtagviIovance Biotherapeutics B.V.Application withdrawnMelanoma

FULL INTELLIGENCE ON LIFILEUCEL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →